Gracell Biotechnologies Inc - ADR

NASDAQ:GRCL   3:59:54 PM EDT
6.48
+0.01 (+0.16%)
Earnings Announcements

Gracell Biotechnologies Reports Third Quarter 2021 Financial Results

Published: 11/15/2021 13:29 GMT
Gracell Biotechnologies Inc - ADR (GRCL) - Gracell Biotechnologies Reports Third Quarter 2021 Unaudited Financial Results and Provides Corporate Update.
Gracell Biotechnologies Inc - Net Loss Attributable to Ordinary Shareholders for Three Months Ended September 30, 2021 Was Rmb129.3 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.07

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.24

More details on our Analysts Page.